fbpx

Viatris and Mylan Epinephine Antitrust and RICO Violations Virginia Complaint

November 1, 2021

The complaint for this class action opens with the words, “This case presents one of the most egregious examples of corporate greed and malfeasance in our nation’s history.” It alleges that the companies behind EpiPens have violated antitrust laws and the Racketeer Influenced and Corrupt Organizations (RICO) Act to maintain a monopoly on the epinephrine market and raise the price of EpiPens exorbitantly. The defendants include Viatris, Inc. (the successor-in-interest to Mylan, NV), Mylan Specialty, LP, Mylan Pharmaceuticals, Inc. and Heather Bresch.

Case Event File: Viatris and Mylan Epinephine Antitrust and RICO Violations Virginia Complaint

Related to: Viatris and Mylan Epinephine Antitrust and RICO Violations Virginia Class Action